A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France

NCT05838664 · clinicaltrials.gov ↗

COMPLETED

Status

2140403

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: No OAC
DRUG: VKA
DRUG: apixaban
DRUG: rivaroxaban
DRUG: dabigatran

Sponsor

Pfizer